This effect of LAIR-1 immuno-suppression on CD8+ T cells potentiates PD-1/PD-L1 blockade resistance in lung tumours in mice [154], demonstrating a key mechanism by which ECM biology impacts upon the ability of the immune system to modulate tumour growth, with implications for immune therapy. The gene discussed is CD8A; the disease is neoplasm.